Direct antiviral therapy for hepatitis C cirrhotic patients in liver transplantation settings: a systematic review
ConclusionDAA therapy for decompensated patients must be personalized with consideration of different factors, particularly among those with MELD scores between the two cutoff-values proposed by the current associational guidelines.
Source: Hepatology International - Category: Infectious Diseases Source Type: research
More News: Antiviral Therapy | Cirrhosis | Hepatitis | Hepatitis C | Infectious Diseases | Liver | Liver Disease | Liver Transplant | Study | Transplant Surgery | Transplants | Urology & Nephrology | Virology